Chad Costley

Dr. Chad Costley, President and CEO of Blue Willow Biologics and an expert in vaccine development, delves into the urgent world of bird flu, particularly H5N1. He discusses the potential for this virus to mutate into a pandemic threat and explores innovative research on an intranasal vaccine that promises to enhance immunity while addressing vaccine hesitancy. Chad highlights the need for accurate public health messaging and shares insights on the hopeful future of vaccine development, including a universal flu vaccine that could revolutionize prevention.